Changeflow GovPing Healthcare & Life Sciences USPTO Patent Applications - Therapeutics (A61P)
Favicon for changeflow.com

USPTO Patent Applications - Therapeutics (A61P)

RSS

GovPing monitors USPTO Patent Applications - Therapeutics (A61P) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 151 changes logged to date.

Monday, March 23, 2026

• USPTO Patent Applications - Therapeutics (A61P)
Favicon for changeflow.com

USPTO Patent Application: Systems for Targeting Cancer Cells

The USPTO has published a new patent application, US20260078200A1, detailing systems and methods for targeting cancer cells using genetically modified immune cells. The application describes novel polypeptides and their use in killing target cancer cells.

Routine Notice Healthcare

Showing 151–151 of 151 changes

← 1 2 3 4

Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

Source details

Country
United States

Activity

Changes tracked
151
Changes in last month
151
Last change detected
7d ago

Filters

Browse Categories

Agriculture & Food Safety 73 Banking & Finance 405 Consumer Protection 87 Courts & Legal 410 Data Privacy & Cybersecurity 84 Defense & National Security 53 Education 55 Energy 100 Environment 151 Gaming 2 Government & Legislation 430 Healthcare 15 Healthcare & Life Sciences 373 Immigration 10 Insurance 74 Labor & Employment 132 Pharma & Drug Safety 21 Professional Licensing 7 Real Estate & Housing 77 Securities & Markets 152 Tax 78 Telecom & Technology 50 Trade & Sanctions 141 Transportation 91

Get USPTO Patent Applications - Therapeutics (A61P) alerts

We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!